Mark Anderson

Founding Chair & CEO at Pattern Computer, Inc

Presenter

Pattern Computer, Inc., a Seattle-area AI & ML company, uses its proprietary Pattern Discovery Engine™ (PDE) to successfully discover, patent and test seven new drug combinations to treat two of the top cancers, which are now ready for human trials. The Company applies the PDE to the challenging fields of drug discovery, multiomics, biomarkers and diagnostics, increasing accuracy, predictability data results, discovering patterns that companies can capitalize on. • Pattern Discovery Engine™- discovers and generates valuable hypotheses and insights into complex data, revealing novel patterns that cannot be discovered using conventional techniques or tools • Life Sciences- diagnostics - identifying signatures in 'omics' and focused on combination and repurposed drugs; diagnostic device that is more accurate, uses no reagents, earlier detection, portable, and providing results in 3 seconds with a small sample of saliva, urine or blood- currently working on COVID and more than eight other diseases with our partners, along with projects focusing on toxicity levels and diseases in saliva with the DoD and two national laboratories. Therapeutics – in oncology, as above. • XAI- analytical tools able to reveal the 'how' and 'why' of a system's predictive success – we challenged ourselves to step up from Generative AI and create our PDE to have the ability to tell you how and why of the results. Called “the most advanced ML company on the planet” by the U.S. Department of Energy. • Commercial engagements- include discovering the critical patterns in breast cancer bioindicators in women's tears, allowing partner to bring this product to market; confirming bioindicators in pancreatic cancer detection; improving global prediction rates for colorectal cancer; improving conjunctivitis diagnostics for surgery requirements.